Consideraciones metodológicas para evaluar el impacto de los síntomas gastrointestinales en pacientes con COVID-19

Zeng W, Qi K, Ye M, Zheng L, Liu X, Hu S, et al. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(2):168-176. https://doi.org/10.1097/MEG.0000000000002072

Matsubara Y, Kiyohara H, Mikami Y, Nanki K, Namkoong H, Chubachi S, et al. Gastrointestinal symptoms in COVID-19 and disease severity: A Japanese registry-based retrospective cohort study. J Gastroenterol. 2024;59(3):195-208. https://doi.org/10.1007/s00535-023-02071-x

Soto A, Quiñones-Laveriano DM, Azañero J, Chumpitaz R, Claros J, Salazar L, et al. Mortality and associated risk factors in patients hospitalized due to COVID- 19 in a Peruvian reference hospital. PLoS One. 2022;17(3):e0264789. https://doi.org/10.1371/journal.pone.0264789

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73(3):566-574. https://doi.org/10.1016/j.jhep.2020.04.006

Gao S, Yang Q, Wang X, Hu W, Lu Y, Yang K, et al. Association between drug treatments and the incidence of liver injury in hospitalized patients with COVID-19. Front Pharmacol. 2022;13:799338. https://doi.org/10.3389/fphar.2022.799338